About
Stem Cell Therapies
Areas of Focus
Categories
Stem Cell & Cellular Therapy
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
7
As Collaborator
3
Total Enrollment
247
By Phase
PHASE1: 5PHASE3: 1PHASE2: 1PHASE1/PHASE2: 1
By Status
COMPLETED: 7ACTIVE_NOT_RECRUITING: 1RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06676423Lead Sponsor
Evaluate the Safety of Neuronata-R® Inj. Suspended With HypoTHermosol® FRS (HTS-FRS) in Patients With ALS
PHASE1Completed
8 participants
Started: Nov 9, 2022 · Completed: Nov 27, 2023
NCT04745299Lead Sponsor
Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients with ALS
PHASE3Active, not recruiting
115 participants
Started: Mar 23, 2021 · Completed: May 3, 2026
NCT04835883Collaborator
Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients
PHASE2Recruiting
10 participants
Started: Sep 26, 2019 · Completed: Jan 20, 2026
NCT04495582Lead Sponsor
Long-term Follow-up of Phase 1 Clinical Trial of CS10BR05(CS10BR05-MSA101)
N/ACompleted
8 participants
Started: Aug 28, 2018 · Completed: Sep 25, 2024
NCT03265444Lead Sponsor
Safety and Tolerability of CS10BR05 Inj. in Subjects with Multiple System Atrophy
PHASE1Completed
9 participants
Started: Apr 13, 2018 · Completed: Dec 5, 2019
Locations (1)
Headquarters
Seongnam, Korea
Map
Loading map...